{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:43:12Z","timestamp":1789627392213,"version":"build-2803163510"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T00:00:00Z","timestamp":1635638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["RP-PG-0217-20009"],"award-info":[{"award-number":["RP-PG-0217-20009"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2021,10,31]]},"abstract":"<jats:p>This study used positive and negative sample panels from Nigeria to test the performance of several commercially available SARS-CoV-2 serological assays. Using these prepandemic and SARS-CoV-2-positive samples, we found much lower levels of sensitivity in four commercially available assays than most assay manufacturer reports and independent evaluations.<\/jats:p>","DOI":"10.1128\/spectrum.00680-21","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T20:46:43Z","timestamp":1633639603000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population"],"prefix":"10.1128","volume":"9","author":[{"given":"Fehintola","family":"Ige","sequence":"first","affiliation":[{"name":"Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9845-4267","authenticated-orcid":true,"given":"Yohhei","family":"Hamada","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0540-9940","authenticated-orcid":true,"given":"Laura","family":"Steinhardt","sequence":"additional","affiliation":[{"name":"Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-8894","authenticated-orcid":true,"given":"Nnaemeka C.","family":"Iriemenam","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Uwandu","sequence":"additional","affiliation":[{"name":"Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie Marta","family":"Greby","sequence":"additional","affiliation":[{"name":"Division of Global HIV and TB, Center for Global Health, Centers for Disease Control and Prevention, Abuja, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Aniedobe","sequence":"additional","affiliation":[{"name":"Clinical Diagnostic Laboratory, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babatunde Lawal","family":"Salako","sequence":"additional","affiliation":[{"name":"Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molebogeng X.","family":"Rangaka","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Abubakar","sequence":"additional","affiliation":[{"name":"Institute for Global Health, University College London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0330-5219","authenticated-orcid":true,"given":"Rosemary","family":"Audu","sequence":"additional","affiliation":[{"name":"Center for Human Virology and Genomics, Microbiology Department, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","unstructured":"World Health Organization. 24 September 2020. Social environmental factors seen behind Africa\u2019s low COVID-19 cases. https:\/\/www.afro.who.int\/news\/social-environmental-factors-seen-behind-africas-low-covid-19-cases. Accessed 9 February 2021."},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003346"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6929e2"},{"key":"e_1_3_3_5_2","volume-title":"Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0.","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Target product profiles for priority diagnostics to support response to the COVID-19 pandemic v.1.0. WHO, Geneva, Switzerland."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104468"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26341"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12397"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2020.121883"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.20506\/rst.17.2.1119"},{"key":"e_1_3_3_11_2","article-title":"Evaluation of nine commercial SARS-CoV-2 immunoassays","author":"Lassauni\u00e8re R","year":"2020","unstructured":"Lassauni\u00e8re R, Frische A, Harboe ZB, Nielsen ACY, Fomsgaard A, Krogfelt KA, J\u00f8rgensen CS. 2020. Evaluation of nine commercial SARS-CoV-2 immunoassays. medRxiv. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.09.20056325v1.","journal-title":"medRxiv"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa200"},{"key":"e_1_3_3_13_2","article-title":"Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin","author":"Emmerich P","year":"2020","unstructured":"Emmerich P, Murawski C, Ehmen C, von Possel R, Pekarek N, Oestereich L, Duraffour S, Pahlmann M, Struck N, Eibach D, Krumkamp R, Amuasi J, Maiga-Ascofare O, Rakotozandrindrainy R, Asogun D, Ighodalo Y, Kann S, May J, Tannich E, Deschermeier C. 2020. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin. medRxiv. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.09.15.20159749v2.","journal-title":"medRxiv"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid2701.203281"},{"key":"e_1_3_3_15_2","volume-title":"SARS-CoV-2 IgG for use with ARCHITECT package insert.","author":"Abbott","year":"2020","unstructured":"Abbott. 2020. SARS-CoV-2 IgG for use with ARCHITECT package insert. Abbott, Chicago, IL."},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jalm\/jfaa204"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103101"},{"key":"e_1_3_3_18_2","volume-title":"Anti-SARS-CoV-2 ELISA (IgG) package insert.","author":"Euroimmun Medizinische Labordiagnostika","year":"2020","unstructured":"Euroimmun Medizinische Labordiagnostika. 2020. Anti-SARS-CoV-2 ELISA (IgG) package insert. Euroimmun, L\u00fcbeck, Germany."},{"key":"e_1_3_3_19_2","article-title":"Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration","author":"Adams ER","year":"2020","unstructured":"Adams ER, Augustin Y, Byrne RL, Clark DJ, Cocozza M, Cubas-Atienzar AI, Cuevas LE, Cusinato M, Davies BMO, Davis M, Davis P, Duvoix A, Eckersley NM, Edwards T, Fletcher T, Fraser AJ, Garrod G, Hadcocks L, Hu Q, Johnson M, Kay GA, Keymer K, Kirwan D, Klekotko K, Lewis Z, Mason J, Mensah-Kane J, Menzies S, Monahan I, Moore CM, Nebe-von-Caron G, Owen SI, Planche T, Sainter C, Schouten J, Staines HM, Turtle L, Williams C, Wilkins J, Woolston K, Sall AA, Fitchett JRA, Krishna S. 2020. Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration. medRxiv. https:\/\/www.medrxiv.org\/content\/10.1101\/2020.04.29.20082099v1.","journal-title":"medRxiv"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104540"},{"key":"e_1_3_3_21_2","volume-title":"Anti-SARS-CoV-2 NCP ELISA IgG package insert.","author":"Euroimmun Medizinische Labordiagnostika","year":"2020","unstructured":"Euroimmun Medizinische Labordiagnostika. 2020. Anti-SARS-CoV-2 NCP ELISA IgG package insert. Euroimmun, L\u00fcbeck, Germany."},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240502"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241104"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0659-0"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02257-20"},{"key":"e_1_3_3_26_2","volume-title":"Anti-SARS-CoV-2-NCP ELISA (IgG) instructions for use.","author":"Euroimmun Medizinische Labordiagnostika","year":"2020","unstructured":"Euroimmun Medizinische Labordiagnostika. 2020. Anti-SARS-CoV-2-NCP ELISA (IgG) instructions for use. Euroimmun, L\u00fcbeck, Germany."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00514-21"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.10.104"},{"key":"e_1_3_3_29_2","unstructured":"U.S. Food & Drug Administration. 2020. Coronavirus disease 2019 (COVID-19) Emergency Use Authorizations for medical devices: in vitro diagnostics EUAs. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas#individual-serological. Accessed 9 February 2021."},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.2677"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.00680-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/Spectrum.00680-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T08:49:27Z","timestamp":1646729367000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/Spectrum.00680-21"}},"subtitle":[],"editor":[{"given":"S. Wesley","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,10,31]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,10,31]]}},"alternative-id":["10.1128\/Spectrum.00680-21"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00680-21","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,31]]},"assertion":[{"value":"2021-06-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00680-21"}}